Gene · 406891
Papers2,321
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,321
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| FN1 mRNA 3'-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3'-UTR-let-7i-5p-THBS1 axis. | Theranostics | 2023 | 37771777 | PubTator, text mining | PubMed |
| Blood miRNA levels associated with ADHD traits in children across six European birth cohorts. | BMC Psychiatry | 2023 | 37749515 | PubTator, text mining | PubMed |
| Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis. | Oncol Res | 2023 | 37744274 | PubTator, text mining | PubMed |
| Seamless and non-destructive monitoring of extracellular microRNAs during cardiac differentiation from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37738969 | PubTator, text mining | PubMed |
| miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. | Technol Cancer Res Treat | 2023 | 37728167 | PubTator, text mining | PubMed |
| Integrated modeling framework reveals co-regulation of transcription factors, miRNAs and lncRNAs on cardiac developmental dynamics. | Stem Cell Res Ther | 2023 | 37705079 | PubTator, text mining | PubMed |
| Standardized Polyalthia longifolia leaf extract induces the apoptotic HeLa cells death via microRNA regulation: identification, validation, and therapeutic potential. | Front Pharmacol | 2023 | 37693900 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. | Oncogene | 2023 | 37670020 | PubTator, text mining | PubMed |
| Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment. | Heliyon | 2023 | 37664708 | PubTator, text mining | PubMed |
| Differential Expression Profiles of Plasma Exosomal microRNAs in Rheumatoid Arthritis. | J Inflamm Res | 2023 | 37663759 | PubTator, text mining | PubMed |
| Corrigendum: Deep sequencing of plasma exosomal microRNA level in psoriasis vulgaris patients. | Front Med (Lausanne) | 2023 | 37663668 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review. | J Reprod Infertil | 2023 | 37663424 | PubTator, text mining | PubMed |
| The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer. | Front Bioeng Biotechnol | 2023 | 37662434 | PubTator, text mining | PubMed |
| Genetics in ophthalmology: molecular blueprints of retinoblastoma. | Hum Genomics | 2023 | 37658463 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation. | Mol Ther Nucleic Acids | 2023 | 37655045 | PubTator, text mining | PubMed |
| Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes. | Stem Cell Res Ther | 2023 | 37649113 | PubTator, text mining | PubMed |
| Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. | Int J Mol Sci | 2023 | 37629204 | PubTator, text mining | PubMed |
| Increased Levels of miR-15b-5p and miR-20b-5p in Pancreatic Ductal Adenocarcinoma with Hepatic Metastases. | Genes (Basel) | 2023 | 37628628 | PubTator, text mining | PubMed |
| Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels. | Cancers (Basel) | 2023 | 37627192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406891/papers?page=6